Because microglial activation is often accompanied by astrogliosis during cancer therapies [21, 26], we tested the effect of combi-ICI on glial interplay by determining the volume of GFAP immunoreactivity (astrocytes) in the DG. This evidence concerns the gene GFAP and cancer.